subcutaneous use
Sponsors
Rhythm Pharmaceuticals Inc., Allergy Therapeutics (UK) Limited
Conditions
Improper function of certain messenger materials in the body that control body weight and hunger in
peopleSeasonal allergic rhinitis/rhinoconjunctivitis induced by grass pollen exposure
Phase 3
A long-term, double-blind, randomised, placebo-controlled clinical trial to investigate the efficacy and safety of PQ Grass 27600 SU in children and adolescents with seasonal allergic rhinitis/rhinoconjunctivitis induced by grass pollen exposure
RecruitingCTIS2023-508520-36-00
Start: 2024-09-06Target: 358Updated: 2025-12-09
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Trial: Multiple Independent Sub-studies of Setmelanotide in Patients with POMC/PCSK1, LEPR, NCOA1 (SRC1), or SH2B1 Gene Variants in the Melanocortin-4 Receptor Pathway
Active, not recruitingCTIS2023-507634-24-00
Start: 2022-05-20Target: 85Updated: 2025-11-28